SCHEMBL17449652

SCHEMBL17449652

CCC(F)(C(=O)C(C)C)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 1/20 0.41
OPRM1 P35372 3/20 0.40
KIF11 P52732 3/20 0.40
GRIN2D O15399 2/20 0.40
GRIN1 Q05586 2/20 0.40
GRIN2A Q12879 2/20 0.40
GRIN2B Q13224 2/20 0.40
GRIN2C Q14957 2/20 0.40
DRD3 P35462 2/20 0.40
CACNA1F O60840 1/20 0.40
ABCB1 P08183 1/20 0.40
CYP2B6 P20813 1/20 0.40
DRD4 P21917 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
CACNA1D Q01668 1/20 0.40
KCNH2 Q12809 1/20 0.40
CACNA1S Q13698 1/20 0.40
CACNA1C Q13936 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4063599 0.81 CYP2C19 (0.44) CYP1A2CYP2D6OPRM1KIF11DRD3
SCHEMBL3364484 0.78 MAPT (0.52) CYP2D6KIF11KCNH2CHRM1CHRM4
SCHEMBL13379448 0.78 CYP2D6 (0.43) CYP1A2CYP2D6OPRM1KIF11GRIN2D
SCHEMBL15113873 0.77 CYP1A2 (0.46) CYP1A2CYP2D6CYP2C19HIF1APTPN1
SCHEMBL10779190 0.76 CES1 (0.53) CHRM1CHRM4CHRM5CYP2C19HIF1A
SCHEMBL27792551 0.75 KCNN4 (0.43) CHRM1CHRM4CHRM5CYP2C19HIF1A
SCHEMBL888776 0.73 CYP1A2 (0.42) CYP1A2CYP2D6KIF11CYP2C19HIF1A
SCHEMBL19464816 0.72 KCNN4 (0.52) CYP1A2CYP2D6OPRM1KIF11GRIN2D
SCHEMBL12824175 0.71 CES1 (0.40) CYP1A2CYP2D6OPRM1KIF11GRIN2D
SCHEMBL888777 0.71 MAPT (0.57) CYP1A2CYP2D6KIF11CYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2809660-B1 MACROCYCLIC COMPOUNDS FOR MODULATING IL-17 ENSEMBLE THERAPEUTICS CORP (US) 2016-01-20 EP disclosed